A practitioner's guide to three documentation gaps most firms working GLP-1 cases do not know they have. 

The GLP-1 litigation is moving fast. Firms that took cases early are now in discovery, building toward bellwether selection. The August 2025 GES ruling changed the evidentiary standard for every gastroparesis claim. NAION became its own MDL in December 2025. Compounded use is surfacing in records firms thought were clean. Firms that understand what is actually in their dockets are in a fundamentally different position than those still finding out.

This guide will show you:

• What the August 2025 gastric emptying study mandate means for every gastroparesis claim in your inventory and how to audit your coverage now

• Why compounded and unbranded GLP-1 use is appearing in records firms did not flag at intake, and what that means for causation

• What the NAION docket looks like right now, why early movers have a genuine advantage, and what firms need to be capturing at intake

• The questions every firm should be able to answer about their GLP-1 docket before bellwether selection begin